Cytomegalovirus (CMV) infection can have both direct and indirect effects after solid-organ
transplantation, with a significant impact on transplant outcomes. Prevention strategies …

Drug‐induced hematological cytopenia is common in kidney transplantation. Various
cytopenia including leucopenia (neutropenia), thrombocytopenia, and anemia can occur in …

Background. Diarrhea of unspecified cause frequently occurs after renal transplantation and
is usually ascribed to mycophenolic acid toxicity. Norovirus (NoV) and sapovirus (SaV) have …

Rationale & Objective The world is facing a global pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Although kidney transplant recipients …

These updated guidelines from the Infectious Diseases Community of Practice of the
American Society of Transplantation provide an update on potential drug‐drug interactions …

Mycophenolate mofetil (MMF) decreases the risk of acute rejection and is associated with
improved graft survival in renal transplant recipients. However, MMF‐related side effects …

BACKGROUND: The optimal approach to cytomegalovirus (CMV) prevention after lung
transplantation is controversial. We recently completed a prospective, randomized, placebo …

Background Additional efficacious immunomodulatory treatment is needed for the
management of immune‐mediated disease in horses. Mycophenolate mofetil (MMF) is an …

Background Leukopenia and neutropenia (L/N) may affect treatment decisions, potentially
resulting in poor clinical and economic outcomes among kidney transplant recipients …

Post transplant anemia (PTA) is a common issue in kidney transplant recipients. Most
importantly it is associated with an impaired allograft function. Other important factors …